Explore Global Companies & Account Intelligence

Depuis 2009, le Groupe JLV, opérant désormais sous la marque Immprove, s’est imposé comme un acteur majeur de l’immobilier d’entreprise. Avec 20 agences et franchises réparties sur le territoire et près de 200 collaborateurs, le Groupe réalise plus de 1 200 transactions chaque année. Immprove reflète une ambition renouvelée et propose une large gamme de services, incluant la transaction, le capital markets, la gestion locative et le conseil aux utilisateurs.

research organisation (CSIR, India)

Immune is a premier Quality and Regulatory consulting company with expertise in computer software and automated solutions. We offer top rated consultants to analyze compliance needs and improve all aspects of regulated operations for our client’s.

Immune System Regulation AB is an innovation driven research company within the area of immunotherapy, based at the Karolinska Hospital in Stockholm, Sweden. The company has a focus on preclinical and clinical research with the objective to be in the forefront of immunotherapy to develop curative drugs for treatment of cancer, HIV, Covid-19, HBV and other infections. Follow us at Twitter: ISR_Innovation

IMMUNE Technology Institute es un centro de estudios tecnológicos en el que podrás realizar tu carrera profesional en desarrollo web, data science, inteligencia artificial, ciberseguridad, o cloud computing. Podrás hacer upskilling para la industria tecnológica con programas inmersivos, con metodología práctica y una tasa de empleabiliad del 95%.

ImmuneBiotech AB - a microbiome company uniquely placed to develop therapeutically effective probiotic products designed using scientific and pharmacologic methods. Our products are scientifically designed combinations of safe probiotic strains. We have a technology platform to select and combine lactobacilli strains to have impact on important pathological alterations, such as: gut microbial dysbiosis, intestinal permeability and mucosal/systemic inflammation. We have access to a library of 150 unique probiotic strains as a base for designing powerful probiotic products. GutMagnific GutMagnific is our first product, scientifically designed for Irritable Bowel Syndrome (IBS) with market launch as a food supplement in 2019. GutMagnific is a patented multi-strain combination of probiotic lactobacilli strains. GutMagnific(R) is expected to be effective on several gut related symptoms including IBS, Myalgic Encephalomyelitis also called Chronic Fatigue Syndrome (ME/CFS), and Clostridium difficile infection (CDI). GutMagnific is the only multi-targeted probiotic product designed to address the three most important hallmarks underlying biological mechanisms of these indications. Try it now at www.GutMagnific.com

Comprehensive enterprise dossier available in global intelligence registry.

The idea for ImmuneSchein Ginger Elixir was created from the herbal traditions my grandfather taught me in Germany as a child. From this upbringing and a trust developed with nature, a product has evolved from my experiences and collaboration with the wonderful properties of foods as a day-to-day immune support to strengthen immunity naturally. Each one of ImmuneSchein’s Ginger Elixirs are handcrafted in small batches, and we take the most care in selecting, prepping and bottling our products to ensure that our customers have the most pristine, pure and natural elixir on the market. Our classic flavor, created with organic ginger root, organic lemon juice and NYS wildflower honey, is just the beginning. We offer seven other ginger elixirs which are extensions of the classic offering by only adding one more ingredient: ⋅ Wild Turmeric Root ⋅ Organic Ceylon Cinnamon Sticks ⋅ Organic Hibiscus Flowers ⋅ Organic Lavender Buds ⋅ Organic Elderberries ⋅ Organic Cardamom Seeds ⋅ Organic Local Garlic ImmuneSchein maintains its product line with respect for centuries of traditions and recipes – while developing our own contemporary twists and flavors from our passion for nature, the environment and people’s happiness and general wellbeing. ImmuneSchein Ginger Elixirs are the best tasting and the most superior ginger elixir products available on the market that can be taken pure without the “gag” effect of many other elixirs. Want to make a ginger detox smoothie, a ginger detox juice, or simply create ginger tasting foods or drinks to support a homeopathic, and holistic approach to general health support or recovery, then ImmuneSchein has you covered. ImmuneSchein Ginger Elixirs are flexible and easy to take with an amazing, an addictive and a one of a kind taste that provides you with the most consistent, potency of our ingredients with every bottle!

Immunetrics takes a Quantitative Systems Pharmacology (QSP) approach to creating mechanistic mathematical models of biological systems, accelerating development of drugs, clinical diagnostics, and medical/commercial devices. We predict FDA-approved endpoints through in silico clinical trial simulations of acute or chronic inflammatory diseases. We deliver proprietary mathematical models encompassing biological pathways and interactions that span levels of detail from intracellular signaling pathways, cell-cell interactions, and organ systems. We also utilize complex analyses to help better understand your data and create novel hypotheses. Our robust bio-simulation platform represents 10+ years of work by our team of experts. Our capabilities allow our clients to bring their health care solutions to market more quickly, at a lower cost, and with decreased risk. Immunetrics was founded in 2001 and collaborates regularly with the most significant names in drug development, medical devices, and academia. Our team includes a cross disciplinary group of experts in physiology, molecular biology, immunology, computational biology, machine learning, and software engineering in a highly collaborative environment. We provide the expertise and experience to build functional models to inform our clients in their decision making process. Immunetrics'​ offices and computing center are conveniently located in South Side of Pittsburgh, PA. Our city is the home of the University of Pittsburgh Medical Center, with its world-class Critical Care Medicine, Surgery and Immunology departments; Carnegie Mellon University, with its world-renowned Engineering and Mathematics groups; and the Pittsburgh Supercomputing Center.

Immuni T is specialized in services for biotherapeutics and immunomodulators at very competitive rates, in particular in customized cell-based assays, flow cytometry analysis and GLP/GCLP bioanalysis. We have developed an ex vivo method for assessing the immunogenic potential of new biotherapeutics and biosimilars, an assay performed in freshly-collected PBMC from a number of donors. This assay, for example, could assist you in the selection of the less immunogenic lead from a set of variants or to compare the immunogenic profile of a biosimilar to that of its originator. It is a rapid and cost-effective means for the evaluation of the immunogenic potential of a molecule in a human system. We perform the development and validation of immunogenicity methods and of ligand-binding assays for PK analysis for pre-clinical and clinical programs. We developed functional customized cell-based assays such as cytotoxicity assays (e.g. ADCC, CDC, in PBMC, sub-cell compartments or whole blood) and other assays such as Treg or NK functional assays. Overall, Immuni T performs cell-based assays, human ex-vivo immunogenicity prediction/comparison assays for new biotherapeutics as well as immunogenicity tests for biotherapeutics in clinical development; ligand-binding assays for the quantification/detection of peptides, proteins or nucleic acids; immuno assays based on flow cytometry analysis for determination of cell function and molecules quantification; multiplex analysis on Luminex as well as customization, development and validation of assays for pre-clinical and clinical sample analysis in a GLP-compliant environment.

IMMUNIS delivers world class Intellectual property (IP) and patent services globally. IMMUNIS is a pioneer in offering Patent services. IMMUNIS provides top-quality, cost effective, customer friendly Patent Search & Analytics, Patent illustrations/Drawings, Drafting & filing, Prosecution and Trademark services across the globe. We specialise in gathering, managing and using IP information to provide you with the services and solutions that matter the most for your business. We take the complexity out of your Intellectual Property Management, so that you concentrate and enrich your business We handle all of your patent needs, doesn’t matter whether they are Computer, Software, Hardware, IT, Electrical & Electronic, Mechanical, Automobile, Medical, Chemistry, DNA sequence or biotech. At Immunis, we understand the true dynamic nature of your business; we continuously refine our processes and set higher standards to provide you with better quality of service. What we offer: Patent Filing and Drafting National Phase Filing (India) PCT Filing Utility and Design Drawings Novelty searches State-of-the-art searches Validity searches Infringement / FTO searches Patent Illustrations/Drawings Trademarks Our Advantage: See why so many companies are turning to 'Immunis'​ for their IP Management Solutions. » Dedicated staff for each client » Timely deliverables » Expert multi-faceted talent pool » Experience » Proven skills » Accurate analysis and reports » Registered patent agents » Cost savings and much more! IMMUNIS Info SERVICES PVT LTD. www.immunisip.com www.immunisdrawings.com Phone No: +1 678 916 6366 Email Id: info@immunisip.com info@immunisdrawings.com

Immunize.org (formerly Immunization Action Coalition) established its website (www.immunize.org) in 1994. It is a nonprofit organization that works to increase vaccination rates and prevent disease through advocacy and education. Immunize.org creates and distributes educational materials for healthcare professionals and the public that enhance the delivery of safe and effective vaccination services. Immunize.org advocates for policies that remove barriers to access to vaccinations for people of all ages and facilitates communication about the safety, efficacy, and use of vaccines within the broad immunization community of patients, parents, healthcare organizations, and government health agencies. For more than three decades, the Centers for Disease Control and Prevention (CDC) has worked in concert with and provided financial support to Immunize.org for the purpose of educating healthcare professionals about U.S. vaccine recommendations. IZ Express is the free weekly e-newsletter produced by Immunize.org with over 54,000 subscribers. IZ Express keeps you informed about important vaccine updates from CDC and FDA. You’ll read about newly posted Vaccine Information Statements and their translations, and new education materials from Immunize.org, CDC, AAP, and other trusted partners. It also features online and in-person educational opportunities, many offering free continuing education credit. To subscribe, simply provide your name and email address at www.immunize.org/subscribe. We will never share your contact information. Disclaimer: www.immunize.org/iacadmin/disclaimer.asp